username :
password :

Remember me

Choose a Channel: | | | |

Cardiovascular
The Economic Times (India) - May. 11, 2008
: US-based Merck has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity.

FEATURED SOLUTIONS PROVIDER
Quick, easy, comprehensive, and accurate, eKnowledgeBase is an interactive online database that provides broad coverage of products, pipelines, and companies from each stage of development through approval and marketing. Updated daily, eKnowledgeBase provides precise, in-depth data on over 26,000 records of compounds in development and brands on the market.

Click here to learn more.



Oncology
The Economic Times (India) - May. 11, 2008
: US-based Merck has received patent approval from the Indian Patent Office for two of its upcoming drugs for dyslipidemia and obesity.


Pain & Inflammation
The Economic Times (India) - May. 11, 2008
Beta: 1.0 Institutional Holding: 31.8% Dividend Yield: 0.07% P/E: 41.5 M-Cap: Rs 16,152 cr CMP: Rs 650.25 Many will wonder why a stock with a high P/E is being recommended, especially at a time when it is trading near record highs.


Central Nervous System
The Australian - May. 11, 2008
AUSTRALIAN scientists have played a vital role in the discovery of a mutant gene linked to a rare condition that causes epilepsy and mental retardation in women. The condition, known as EFMR, is found only in particular families and ...


Infectious Disease
The Times of India - May. 11, 2008
NEW DELHI: The first quarter of this year has witnessed a change in the domestic pharma retail market with antibiotics and anti-bacterial drugs dominating the show in top 10 brands.


 

Paid Advertisement

TherapeuticsDaily.com is free with registration.
Created by PharmaLive.com, receive the best of therapeutic news directly into your E-mail box.
unsubscribe   |   privacy policy   |   media kit ©2008 Canon Communications Pharmaceutical Media Group